Gain Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Gain Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • Gain Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 26.5M shares, a 109% increase year-over-year.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 13M shares, a 9.49% increase from 2022.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 11.9M shares, a 16.9% increase from 2021.
  • Gain Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 10.2M shares, a 279% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 13M +1.13M +9.49% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 11.9M +1.72M +16.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 10.2M +7.48M +279% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 2.68M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.